MRI

Enis C Yilmaz1, Stephanie A Harmon1, Yan Mee Law1

  • 1From the Molecular Imaging Branch (E.C.Y., S.A.H., M.J.B., Y.L., D.G.G., K.B.O., N.S.L., P.E., P.L.C., B.T.), Biometric Research Program, Division of Cancer Treatment and Diagnosis (E.P.H.), Center for Interventional Oncology (L.A.H., C.G., B.J.W.), Department of Radiology, Clinical Center (L.A.H., C.G., B.J.W.), Laboratory of Pathology (A.T., M.J.M.), and Urologic Oncology Branch (S.G., P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892; Department of Radiology, Singapore General Hospital, Singapore (Y.M.L.); and NVIDIA Corporation, Santa Clara, Calif (D.Y., Z.X., J.T., D.X.).

Radiology. Imaging cancer
|October 14, 2024
PubMed
概括

一个人工智能 (AI) 模型在外部双参数核磁共振扫描 (bpMRI) 上检测前列腺癌病变方面表现适度,在内部扫描上检测能力得到改善. 关键词:人工智能,前列腺癌,bpMRI.